PNC Financial Services Group Inc. PNC, -0.35% said Tuesday it’s purchasing a $16.6 billion portfolio of Signature Bridge Bank NA commitment facilities from the Federal Insurance Deposit Corp. for an undisclosed sum….
Tag: Corporate/Industrial News
Netflix Plans to Raise Subscription Prices After Actors Strike Ends
What to Read Next Source link
Senators Probe TikTok's Executive Transfers From ByteDance
The senators want information about TikTok’s ties to its parent, including whether it disclosed recent personnel moves to the U.S. government. Source link
As Tesla Deliveries Sputter, BYD Looks Alluring
Tesla appears overvalued when compared with traditional carmakers. Less appreciated is the huge valuation gap that has opened up relative to its closest electric-vehicle peer. Source link
Meta Plans to Charge $14 a Month for Ad-Free Instagram
European users would have the option to pay a fee or agree to personalized ads, according to the company’s pitch to regulators. Source link
U.S. Car Sales Expected to Increase Again in the Third Quarter
The car market has yet to see an impact from UAW strike-related factory shutdowns. Source link
Vivek Ramaswamy's Former Company Is Doing Just Fine Without Him
Roivant wouldn’t be where it is without the Republican presidential candidate, but his departure has made the company more palatable to Wall Street. Source link
Japan to Give Micron Technology $1.28 Billion Aid for Chip Project at Hiroshima Plant
By Kosaku Narioka The Japanese government will give an aid of over a billion dollars to Micron Technology’s memory chip project at its Hiroshima plant, the country’s trade minister said, as part…
Boohoo Cuts Revenue Views on Slower Volume Recovery
By Michael Susin Boohoo Group has downgraded its fiscal 2024 revenue targets on slower-than-expected sales volume recovery, and reported a widened pretax loss for the first half. The London-listed online fashion retailer…
Eli Lilly gets FDA complete response letter for skin treatment after inspection of third-party facility
Eli Lilly & Co. said Monday the U.S. Food and Drug Administration has issued a complete response letter for its lebrikizumab, a treatment for moderate-to-severe atopic dermatitis, after an inspection at a…